Sepsis: A Review of Advances in Management

dc.contributor.authorRello, Jordi
dc.contributor.authorValenzuela-Sanchez, Francisco
dc.contributor.authorRuiz-Rodriguez, Maria
dc.contributor.authorMoyano, Silvia
dc.contributor.authoraffiliation[Rello, Jordi] Vall dHebron Inst Res, CIBERES, Barcelona, Spain
dc.contributor.authoraffiliation[Ruiz-Rodriguez, Maria] Vall dHebron Inst Res, CIBERES, Barcelona, Spain
dc.contributor.authoraffiliation[Moyano, Silvia] Vall dHebron Inst Res, CIBERES, Barcelona, Spain
dc.contributor.authoraffiliation[Valenzuela-Sanchez, Francisco] Hosp Univ Jerez, Crit Care Dept, Jerez de la Frontera, Spain
dc.contributor.funderCIBERES
dc.contributor.funderFISS, Instituto de Salud Carloos III, Madrid, Spain
dc.date.accessioned2025-01-07T12:53:31Z
dc.date.available2025-01-07T12:53:31Z
dc.date.issued2017-11-01
dc.description.abstractInfections represent a common health problem in people of all ages. Usually, the response given to them is appropriate and so little treatment is needed. Sometimes, however, the response to the infection is inadequate and may lead to organ dysfunction; this is the condition known as sepsis. Sepsis can be caused by bacteria, fungi or viruses and at present there is no specific treatment; its management basically focuses on containing the infection through source control and antibiotics plus organ function support. This article reviews key elements of sepsis management, focusing on diagnosis, biomarkers and therapy. The main recent advance in therapy is the strategy of personalized medicine, based on a precise approach using biomarkers to identify specific individuals who are likely to benefit from more personalized attention.
dc.identifier.doi10.1007/s12325-017-0622-8
dc.identifier.essn1865-8652
dc.identifier.issn0741-238X
dc.identifier.pmid29022217
dc.identifier.unpaywallURLhttps://europepmc.org/articles/pmc5702377?pdf=render
dc.identifier.urihttps://hdl.handle.net/10668/25024
dc.identifier.wosID416262300001
dc.issue.number11
dc.journal.titleAdvances in therapy
dc.journal.titleabbreviationAdv. ther.
dc.language.isoen
dc.organizationSAS - Hospital Universitario de Jerez de la Frontera
dc.page.number2393-2411
dc.publisherSpringer
dc.rightsAttribution-NonCommercial 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/
dc.subjectBacteremia
dc.subjectCritically ill patients
dc.subjectPneumonia
dc.subjectSepsis
dc.subjectSeptic shock
dc.subjectCritically-ill patients
dc.subjectC-reactive protein
dc.subjectHla-dr expression
dc.subjectRegional pro-adrenomedullin
dc.subjectGoal-directed therapy
dc.subjectSeptic shock
dc.subjectImmunomodulatory therapy
dc.subjectAntimicrobial therapy
dc.subjectEmergency-department
dc.subjectAntibiotic-therapy
dc.titleSepsis: A Review of Advances in Management
dc.typereview
dc.type.hasVersionVoR
dc.volume.number34
dc.wostypeReview

Files